The lengths authors have to go through to publish these daysβ¦
20.10.2025 00:17
π 1
π 0
π¬ 0
π 0
The lengths authors have to go through to publish these daysβ¦
Pho is overrated. BΓΊn mΔm is where itβs at.
Any updates?
-PI
What is the relevance?
-Reviewer 2
A big congratulations to my colleagues Bo Zhang and Prajish Iyer @prajishiyer.bsky.social on their co-first author publication in @jci-insight.bsky.social! Many years of work and labor @cityofhope.bsky.social.
insight.jci.org/articles/vie...
Now we need a Les Grossman movie.
And that concludes my time @cityofhope.bsky.social! Many gratitude to IMGS and to my advisors Lili Wang @wanglabcityofhope.bsky.social and RJ Lin for their years of guidance and support! Iβm off now to my adventure but what I learned here will stay with me forever!
Congratulations to my graduate student, Erica Niewold @ericalytical.bsky.social, for being selected by @ash.hematology.org to receive the ASH Graduate Hematology Award (AGHA)! #ASHAwards
Congrats @ericalytical.bsky.social!
At this yearβs #RNA25, I will be presenting our work on identifying co-factors important for SF3B1 mutation-driven backsplicing!
Excited to be in San Diego for another RNA meeting from @rnajournal.bsky.social! Looking forward to all the amazing science! #RNA25
Thrilled to share that my PhD student, Mike Fernandez, has successfully defended his thesis! His hard work and dedication have led to incredible contributions to RNA splicing field. Congratulations, Dr. Fernandez! @mikemfernandez.bsky.social
Congrats @wanglab.bsky.social!
Dopest Dough. Is that your rapper name? You about to drop a diss track? Maybe hand out demo CDs? Rap battle at the local Waffle House for extra street creds?
Huge #ASHKudos to my graduate student @mikemfernandez.bsky.social who was honored with a Distinguished ASH award at #ASH24! He was interviewed by @ash-hematology.bsky.social on his work, which is on the role of SF3B1 mutation and LOY!
The time limit also gives an enormous advantage to large labs with pre-established projects for junior PhDs to pick up and write fellowships on. With the F32, you can spend extra time putting together a stronger proposal and get funded, even if the funding time is shorter.
It used to be F31>F99>F32>K99. Like the F31, the F32 provides 3 years of support and is only limited by how much time you have in your PhD. The K32 puts a strict limit of 2 years into postdoc. The K99 is now out to 6 years but very competitive. That leaves little for the mid-stage postdocs.
I wonder what happens to the F99 now. The F99 requires more data and ideally a paper from pre-doctoral training but has significant overlap in training coverage and also no citizenship requirement.
Huge congratulations to both @tjflemin.bsky.social and @bloodgenes.bsky.social! Both Outstanding Abstract Achievement Award and Best of ASH! #ASH24 #ASHKudos @ash-hematology.bsky.social
Lili Wang lab from City of Hope, we are here at Bluesky!
And thatβs a wrap for #ASH24. It has been a wonderful experience, meeting with old and new colleagues, presenting my first ASH oral presentation, receiving a distinguished award courtesy of @ash-hematology.bsky.social, and seeing and learning all of the exciting science.
Thank you!
The things people do for science.
Leave it to the @oawlab.bsky.social to do something out of the box. Splicing factor mutation-associated neoantigens is an exciting field. #ASH24
Big thanks to @ash-hematology.bsky.social for giving me the opportunity to present our work at #ASH24.
Leave it to Elizabeth Bonner @ebonner.bsky.social to slay her talk at #ASH24. Amazing talk!
Big thanks to @ash-hematology.bsky.social for the award! I am incredibly honored and grateful! #ASH24
Happening today! I will be giving a talk on how SF3B1 mutation promotes loss of Y chromosome at #ASH24
